About: Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 2003

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) bài báo khoa học (vi) наукова стаття, опублікована в травні 2003 (uk) im Mai 2003 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 2003 (ast) scientific article published on 01 May 2003 (en)
publication date	wds:Q73344211-2840037F-5128-4EC0-AF23-A303FE0F2049
publication date	2003-05-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q73344211-07CE9F06-C26F-4F86-BFA7-4177240BDD19 wds:Q73344211-2EB7C6E2-8F3B-4CDA-8B58-2FC7B45F4A35 wds:Q73344211-B0E23156-FC53-4C75-8C5A-DF36D8D126B5 wds:Q73344211-D30C6070-BF36-4EDB-9D14-81F1E8EACB03 wds:Q73344211-F673A335-D5AF-4DFC-BF1B-EFBCF83460F6 wds:Q73344211-F9288C4F-218D-4980-B5FD-075291A80619 wds:Q73344211-FF5825F6-346C-414A-8885-56CE6D21E61F
author name string	Yoshihide Ogawa Kanji Nagai Tomoyuki Kamijo Tomoyuki Yokose Masato Goya Tadashi Hatano Hiroyuki Yonou
rdfs:label	Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice (en) Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice (nl)
skos:prefLabel	Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice (en) Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice (nl)
name	Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice (en) Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice (nl)
author	wds:Q73344211-77746098-CB3A-49D8-81C2-464845051662 wds:Q73344211-9DA74321-9F16-41F0-BE99-87B73891B622 wds:Q73344211-B5043073-EAF7-4D2F-A775-18CE4727F692
author	Atsushi Ochiai Naoki Kanomata Takahiro Hasebe
title	wds:Q73344211-358DAAE1-D8E6-41CA-AB9B-588B86B11A47
title	Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice (en)
page(s)	wds:Q73344211-A9AF10FF-63BA-46BF-8986-AB4E3A747E88
page(s)	2096-2102
instance of	wds:Q73344211-4A657AAB-D93D-4EB5-BF5C-30EC6266D304
instance of	scholarly article
main subject	wds:Q73344211-8AAF70B3-05C4-4919-9C51-370BBD4FF765
main subject	prostate cancer
PubMed ID	wds:Q73344211-9C753674-CCF3-43E3-9513-A35BE97C49A3
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12727825
PubMed ID	12727825
published in	wds:Q73344211-F4357919-B909-4A84-A59A-01CCE4905A26
published in	Cancer Research
issue	wds:Q73344211-2BC98688-628E-40FC-A32D-2761E1C260AB
volume	wds:Q73344211-D29772C9-2AED-4AD5-911E-AF93D0CA6CF8
issue	9
volume	63
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73344211
is cites work of	Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein Dasatinib inhibits both osteoclast activation and prostate cancer PC-3-cell-induced osteoclast formation Targeting of bone-derived insulin-like growth factor-II by a human neutralizing antibody suppresses the growth of prostate cancer cells in a human bone environment Therapeutic efficacy of soluble receptor activator of nuclear factor-kappa B-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma Expression of osteoprotegerin from a replicating adenovirus inhibits the progression of prostate cancer bone metastases in a murine model The effect of osteoprotegerin administration on the intra-tibial growth of the osteoblastic LuCaP 23.1 prostate cancer xenograft Roles of osteoclasts and bone-derived IGFs in the survival and growth of human breast cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice Skeletal and extraskeletal actions of denosumab. The effect of zoledronic acid and osteoprotegerin on growth of human lung cancer in the tibias of nude mice. Denosumab and bone metastasis-free survival in men with nonmetastatic castration-resistant prostate cancer: exploratory analyses by baseline prostate-specific antigen doubling time Down-regulation of osteoprotegerin expression as a novel biomarker for colorectal carcinoma The role of RANK-ligand inhibition in cancer: the story of denosumab A humanized tissue-engineered in vivo model to dissect interactions between human prostate cancer cells and human bone Harnessing the versatile role of OPG in bone oncology: counterbalancing RANKL and TRAIL signaling and beyond Denosumab: A comprehensive review Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model Osteoclast inhibitors to prevent bone metastases in men with high-risk, non-metastatic prostate cancer: A systematic review and meta-analysis. Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells. Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL
is cites work of	wds:Q33575740-B3009574-FEE9-4E2E-8DA9-06B6C53D5C97 wds:Q37227675-37136010-D264-4C0E-B614-91DEC6EEDB0E wds:Q36644377-874A0852-74A1-4E70-A1F1-14F83AA5E737 wds:Q90442956-6C548F02-7C60-45E6-9FD7-40AD060271EB wds:Q40007933-562A7805-1B22-49BE-9A70-5421C4E247FD wds:Q53621774-490C9C78-95ED-4F04-A65E-B8EA0A1CBEE5 wds:Q81323685-D7AA2CAD-5B16-456A-BAAB-09BC3761D244 wds:Q48371276-F2986B44-CFCE-4774-9100-602566EC546C wds:Q36491545-FEBB0624-E9DA-499C-8DDC-EF6AE2908E89 wds:Q37409192-1E4F2A22-6344-4DD0-828C-EDAFBEF324E3 wds:Q37467278-D66492D6-F50F-41AA-AFF2-3347DD803386 wds:Q34770095-6690CBD9-FDAD-4D80-8C38-DECF81D93238 wds:Q37046838-88C7664D-7CEB-48A8-9705-5CC364335F32 wds:Q39783688-44B29C42-2C61-40D7-82AD-48515FD9DD82 wds:Q36860987-C2454052-08FB-4A06-9B0D-DA271EF3DE8A wds:Q24633284-ABB9BA79-E945-44EF-A6AA-10B098C13418 wds:Q38009712-EE39EBD1-B52A-490A-BC33-C80DB7087824 wds:Q39253746-F1C2A540-FA57-40C0-9A27-3DCD4BD5FB66 wds:Q47712068-93505D4F-EC28-463B-BB6E-943063619DDA wds:Q39794430-8AC17D6E-9E63-41FE-BD37-2928E0663AEE

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software